Sign Up to like & get
recommendations!
1
Published in 2021 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2021.2016698
Abstract: ABSTRACT Introduction Nocturia is a common urinary complaint among patients presenting with lower urinary tract symptoms and in recent years, there is a greater emphasis to tailor the treatment for nocturia in a more holistic…
read more here.
Keywords:
oral drug;
drug therapies;
treatment nocturia;
drug ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Infectious Diseases"
DOI: 10.1080/23744235.2022.2058604
Abstract: Abstract Background The newly emerged pandemic of coronavirus disease-2019 (COVID-19) is the world's main health challenge because infected patients become vulnerable to a variety of opportunistic diseases. Objective This study aimed to assess clinical outcomes,…
read more here.
Keywords:
clinical outcomes;
covid mucormycosis;
drug therapies;
mucormycosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000010123
Abstract: Background: The standardization for the clinical use of drug therapy for cerebral infarction (CI) has not yet determined in some aspects. In this paper, we discussed the efficacies of different drug therapies (aspirin, aspirin plus…
read more here.
Keywords:
aspirin plus;
cerebral infarction;
rate;
drug therapies ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "British Medical Journal"
DOI: 10.1136/bmj.j840
Abstract: New guidelines from the American College of Physicians recommend that physicians avoid prescribing drugs, particularly opioids, to treat acute and subacute low back pain and should instead emphasize non-pharmacologic therapies, such as superficial heat, massage,…
read more here.
Keywords:
non drug;
back pain;
treatment;
low back ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Annual review of pharmacology and toxicology"
DOI: 10.1146/annurev-pharmtox-010818-021059
Abstract: Though ursodeoxycholic acid (UDCA) remains the baseline treatment for most cholestatic liver diseases, UDCA treatment leaves approximately one-third of patients with primary biliary cholangitis (PBC) and all patients with primary sclerosing cholangitis (PSC) at risk…
read more here.
Keywords:
cholestatic liver;
liver diseases;
pharmacology;
drug therapies ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of Parkinson's Disease"
DOI: 10.3233/jpd-229002
Abstract: Background: As the international community dealt with the ongoing COVID-19 pandemic, important progress continued to be made in the development of new drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD) in 2021. This…
read more here.
Keywords:
clinical trials;
parkinson disease;
drug therapies;
clinical trial ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231911550
Abstract: Growing evidence supports the presence of social cognition deficits and social behavior alterations in major and minor neurocognitive disorders (NCDs). Even though the ability to identify socio-emotional changes has significantly improved in recent years, there…
read more here.
Keywords:
social cognition;
social behavior;
drug therapies;
evidence ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15101242
Abstract: Pulmonary hypertension (PH) is characterized by a resting mean pulmonary artery pressure (PAP) of 20 mmHg or more and is a disease of multiple etiologies. Of the various types of PH, pulmonary arterial hypertension (PAH)…
read more here.
Keywords:
pulmonary hypertension;
hypertension;
therapies pulmonary;
strategizing drug ... See more keywords